Schweizer E, Pohl R, Balon R, Fox I, Rickels K, Yeragani V K
Department of Psychiatry, University of Pennsylvania.
Pharmacopsychiatry. 1990 Mar;23(2):90-3. doi: 10.1055/s-2007-1014489.
Sixty-seven patients with panic disorder were treated with single-blind placebo for one week before being randomized to 6 weeks of double-blind treatment with either lorazepam or alprazolam. Both drugs showed significant and comparable antipanic efficacy throughout the course of the study. With the exception of sedative effects, both drugs were well-tolerated at a mean daily dose of 7 mg for lorazepam and 3 mg for alprazolam. Lorazepam appeared to be as effective as alprazolam in the acute treatment of panic disorder.
67名惊恐障碍患者在被随机分配接受为期6周的劳拉西泮或阿普唑仑双盲治疗之前,先接受了为期一周的单盲安慰剂治疗。在整个研究过程中,两种药物均显示出显著且相当的抗惊恐疗效。除了镇静作用外,两种药物在劳拉西泮平均每日剂量7毫克和阿普唑仑平均每日剂量3毫克时耐受性良好。劳拉西泮在惊恐障碍的急性治疗中似乎与阿普唑仑一样有效。